Innovator Presentation Track

The Innovator Presentation track featured 31 novel research approaches that can move a field of research forward. Each 25-minute presentation was a tangible case study on an innovative, cross-sector approach to medical research, development, funding and/or partnering.

Innovator Presentation Highlights
Partnering with other organizations – from for-profit companies to government agencies and non-profits – is not for the faint of heart. But the rewards can be huge. More...

The following programs were featured at Partnering for Cures:

• Accelerated Cure Project Biorepository
   Presented by: Hollie Schmidt, Vice President of Scientific Operations, Accelerated Cure Project for Multiple Sclerosis
  

  	2:30 pm – 2:55 pm Room: Alvin



• The Accelerator of Cancer Treatments in Children
   Presented by: Beth Anne Baber, Ph.D., M.B.A., Co-Founder and CEO, The Nicholas Conor Institute for Pediatric Cancer Research
  

  	10:45 am – 11:10 am Room: Uris



• BioPontis Alliance
   Presented by: Barbara Handelin, President, BioPontis Alliance, LLC
  

  	4:00 pm – 4:25 pm Room: Broadway



• Cancer Commons
   Presented by: Jay M. Tenenbaum, Chairman, CEO and Chief Scientist, CollabRx
  

  	11:00 am – 11:25 am Room: Broadway



• Cancer E-Life Collaboration
   Presented by: Ken Buetow, Ph.D., Associate Director, Bioinformatics and Information Technology, National Cancer Institute and Jon Handler M.D., Chief Architect, Microsoft Health Solutions Group
  

  	10:30 am – 10:55 am Room: Broadway



• Centre for Drug Research and Development
   Presented by: Natalie Dakers, President and CEO, Centre for Drug Research and Development
  

  	10:15 am – 10:40 am Room: Broadway



• Cerebrospinal Fluid Quality Control Initiative
   Presented by: Maria Carrillo, Ph.D., Senior Director, Medical and Scientific Relations, Alzheimer's Association
  

  	11:00 am – 11:25 am Room: Alvin



• Clinical Trial Comparator Arm Partnership
   Presented by: Sharon Terry, M.A., President and CEO, Genetic Alliance; Stephen Friend, M.D., Ph.D., President, Sage Bionetworks

	11:15 am – 11:40 am Room: Broadway



• DART Therapeutics
   Presented by: Eugene Williams, Chairman, DART Therapeutics, LLC
  

  	3:30 pm – 3:55 pm Room: Broadway



• Discontinued Clinical Compound Library: Academic Drug Repositioning
  Presented by: Kate Marusina, Ph.D., Manager, Industry Alliances, Clinical and Translational Sciences Center, University of California, Davis
  

  	4:00 pm – 4:25 pm Room: Alvin



• Enabling Molecularly Informed Cancer Medicine, National Cancer Institute
   Presented by: Richard Aragon, Ph.D., Director, IMAT Program, National Cancer Institute, and Anthony Dickherber, Ph.D., Office of the Director, National Cancer Institute
  

  	3:30 pm – 3:55 pm Room: Alvin



• The Epilepsy Study Consortium
  Presented by: Jacqueline A. French, M.D., President, and Joyce A. Cramer, President, Epilepsy Therapy
  

  	4:00 pm – 4:25 pm Room: Regency



• Fast Forward – EMD Serono Collaboration
   Presented by: Timothy Coetzee, President, Fast Forward, LLC
  

  	10:15 am – 10:40 am Room: Uris



• findAKUre
  Presented by: Dr. Nicolas Sireau, Chairman, AKU Society, United Kingdom, and Dr. Lakshminarayan Ranganath, Consultant Chemical Pathologist and Honorary Senior Lecturer, Royal Liverpool University Hospital, United Kingdom
  

  	3:30 pm – 3:55 pm Room: Regency



• Global Health Portfolio, Foundation for the NIH
   Presented by: Scott E. Campbell, Ph.D., Executive Director and CEO, Foundation for the National Institutes of Health

	10:45 am – 11:10 am Room: Alvin



• Health Impact Fund Pilot, Incentives for Global Health
  Presented by: Harvey Rubin, Professor of Medicine, University of Pennsylvania, and Chair of the Scientific Advisory Committee, Incentives for Global Health
  

  	3:00 pm – 3:25 pm Room: Regency



• Health of Women Study
   Presented by: Naz Sykes, Executive Director, Dr. Susan Love Research Foundation
  

  	10:15 am – 10:40 am Room: Alvin



• Hospital Medicine Reengineering Network
   Presented by: Aaron Abend, Managing Director–Data Warehousing, Recombinant Data Corporation

	10:45 am – 11:10 am Room: Broadway



• International AIDS Vaccine Initiative, Innovation Fund
   Presented by: Seth Berkley, M.D., President and CEO, International AIDS Vaccine Initiative
  

  	4:00 pm – 4:25 pm Room: Uris



• International Partnership for Microbicides
  Presented by: Pamela M. Norick, Chief of External Relations, and Michael E. Green, Executive Director of Resource Development, International Partnership for Microbicides
  

  	2:30 pm – 2:55 pm Room: Regency



• Ivy Genomics Based Medicine Project
   Presented by: Michael E. Berens, Ph.D., Director and Senior Investigator, Translational Genomics Research Institute
  

  	3:30 pm – 3:55 pm Room: Uris



• LaunchPad Fund, Biomedical Innovation in Diabetes
   Presented by: Greg Fralish, Program Director, Translational Research, and Mark Crowell, Executive Director and Associate Vice President, Innovation Partnerships and Commercialization, University of Virginia
  

  	2:30 pm – 2:55 pm Room: Broadway



• Melanoma Research Alliance Academic-Industrial Partnership Awards
   Presented by: Suzanne L. Topalian, M.D., Chief Science Officer, and Laura Brockway-Lunardi, Ph.D., Scientific Program Director, Melanoma Research Alliance
  

  	3:00 pm – 3:25 pm Room: Uris



• Multiple Myeloma Research Foundation, Personalized Medicine Initiative
   Presented by: Kathy Giusti, Founder and CEO, Multiple Myeloma Research Foundation, and Gerald McDougall, Partner, PricewaterhouseCoopers, MMRF and MMRC Board Member
  

  	10:30 am – 10:55 am Room: Alvin



• Neurofibromatosis Preclinical Consortium
   Presented by: Kim Hunter-Schaedle, Ph.D., Chief Scientific Officer, Children's Tumor Foundation
  Uris/Julliard

	11:15 am – 11:40 am Room: Uris



• OncoNet
   Presented by: Eliav Barr, Vice President, Oncology Clinical Research, Merck Research Laboratories
  

  	3:00 pm – 3:25 pm Room: Alvin



• Parkinson's Progression Markers Initiative
   Presented by: Sohini Chowdhury, Vice President, Research Partnerships, Michael J. Fox Foundation for Parkinson's Research

	11:15 am – 11:40 am Room: Alvin



• Product Development Partnership for a Malaria Vaccine: PATH Malaria Vaccine Initiative, GlaxoSmithKline Biologicals
   Presented by: Christian Loucq, M.D., Director, PATH Malaria Vaccine Initiative
  

  	10:30 am – 10:55 am Room: Uris



• Seaside Therapeutics, Merck, NIH, FRAXA, and Autism Speaks
   Presented by: Randall L. Carpenter, M.D., President and CEO, Seaside Therapeutics, and Linda Brady, Ph.D., Director, Division of Neuroscience & Basic Behavioral Science, National Institute of Mental Health
  

  	2:30 pm – 2:55 pm Room: Uris



• Tolerx-Cancer Research Institute Acceleration Fund
   Presented by: Christopher Merrill, Director, Business Development, Tolerx, Inc., and Adam Kolom, Director, Cancer Vaccine Acceleration Fund, Cancer Research Institute
  

  	11:00 am – 11:25 am Room: Uris

• Presenting organizations may include nonprofit foundations, pharmaceutical and/or biotechnology companies, research institutes, universities, government agencies, investors and private philanthropists


• Presenters must be engaged in, or in the process of launching, a collaborative project/initiative/process for accelerating the development and/or commercialization of new medical solutions (Please indicate existing partners through your applicant questionnaire)


• Any partner may apply, but FasterCures will only review one application per partnership Please note, selected initiatives/partnerships will be limited to no more than two presenters each

• Degree to which initiative/partnership demonstrates ability (or potential) to transform the biomedical research and development enterprise
• Degree to which initiative/partnership is scalable across diseases and sectors
• Degree to which novel R&D processes and strategies are employed
• Clarity of planning and measurement strategy (e.g., defined milestones, timelines for implementation, metrics for success)
• Level of demonstrated impact against mission and objectives